These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 346212
1. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Ochs JJ, Freeman AI, Douglass HO, Higby DS, Mindell ER, Sinks LF. Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212 [Abstract] [Full Text] [Related]
3. Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Gasparini M, Rouesse J, van Oosterom A, Wagener T, Somers R, Russel JA, Voûte PA, Bramwell V, Thomas D, Sylvester R. Cancer Treat Rep; 1985 Feb; 69(2):211-3. PubMed ID: 3855699 [Abstract] [Full Text] [Related]
4. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Chary KK, Higby DJ, Henderson ES, Swinerton KD. Cancer Treat Rep; 1977 Feb; 61(3):367-70. PubMed ID: 266972 [Abstract] [Full Text] [Related]
5. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study. Samson MK, Baker LH, Benjamin RS, Lane M, Plager C. Cancer Treat Rep; 1979 Feb; 63(11-12):2027-9. PubMed ID: 575067 [Abstract] [Full Text] [Related]
6. [Cis-dichlorodiammineplatinum in osteosarcoma. Osteosarcoma Cooperative Study Group report]. Fukuma H, Beppu Y, Chuman H, Yagi T, Yamawaki S, Isu K, Funayama K, Tanuma M, Abe Y, Toriyama S. Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):811-7. PubMed ID: 2653222 [Abstract] [Full Text] [Related]
7. Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group. Morgan E, Baum E, Bleyer WA, Movassaghi N, Provisor A, Lampkin B, Lukens J, Griffin T, White H, Fryer C. Cancer Treat Rep; 1984 Apr; 68(4):661-4. PubMed ID: 6370429 [Abstract] [Full Text] [Related]
8. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175 [Abstract] [Full Text] [Related]
9. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children. Kamalakar P, Freeman AI, Higby DJ, Wallace HJ, Sinks LF. Cancer Treat Rep; 1977 Aug 15; 61(5):835-9. PubMed ID: 890692 [Abstract] [Full Text] [Related]
12. [Chemotherapy using cisplatin in bone and soft tissue sarcoma]. Isu K, Goto M, Yamawaki S, Ubayama Y. Gan To Kagaku Ryoho; 1987 Jan 15; 14(1):100-4. PubMed ID: 3467652 [Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups. J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977 [Abstract] [Full Text] [Related]
18. Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases. Rosenburg SA, Flye MW, Conkle D, Seipp CA, Levine AS, Simon RM. Cancer Treat Rep; 1979 May 01; 63(5):753-6. PubMed ID: 287554 [Abstract] [Full Text] [Related]
20. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy. Gilchrist GS, Ivins JC, Ritts RE, Pritchard DJ, Taylor WF, Edmonson JM. Cancer Treat Rep; 1978 Feb 01; 62(2):289-94. PubMed ID: 346219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]